Legal battle over Novo Nordisk's semaglutide drug in India, with DRL, raises concerns over patent infringement and drug ...

A legal tangle hovers over Novo Nordisk’s diabetes and weightloss ... Health Organization to endorse the inclusion of rapid-acting insulin analogues and GLP-1 receptor agonists (RAs) on the ...

Novo Nordisk's insulin aspart franchise is a ... having a biosimilar option for their rapid-acting insulin injection can truly make a difference, as biosimilar products have the potential to ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...

Scientists have unearthed surprising details about how our bodies handle insulin—the hormone that plays a crucial role in ...

Scientists have unearthed surprising details about how our bodies handle insulin – the hormone that plays a crucial role in ...

Scientists discover unique insulin responses in each person, opening new paths for early diabetes detection and treatment.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Taking a statin medication is an effective, safe, and low-cost way to lower cholesterol and reduce risk of cardiovascular events. Despite clinicians recommending that many patients with diabetes take ...